Category Archives: Biotechnology

News stories about iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) have been gaining in popularity quite recently, Accern reports. The analysis company ranks negative and positive press coverage by studying larger than 20 Million SEC financial documents and social media sites sources in real-time. Accern grades analysis of companies ranging from -1 to 1, with ranks nearest to 1 is considered more positive. iShares Nasdaq Biotechnology Index Fund achieved a news impact rank of 0.10 on Accerns range. Accern also gave media analysis about the financial services provider a media impact point of 0 out of 100, indicating that recent press coverage is very unlikely to have an effect on the firms share value next many days. Stocks of iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) started trading at 310.95 on early Tue. the company has 50 Day SMA price of $297.52 and a two hundred SMA of $288.98. iShares Nasdaq Biotechnology Index Fund has a 1 year low of $246.71 and a 1 year high of $323.45. Few press stories that May have effected Accern trend Analysiss analysis: Also, the company disclosed a divided for the quarter, to be paid on early Fri, Jun 30th. Traders who own the stock with … Continue reading →

A team of researchers at the University of Melbourne has used a quantum probe to perform microwave-free NMR at the nanoscale. Researchers at the University of Melbourne have demonstrated a way to detect nuclear spins in molecules non-invasively, providing a new tool for biotechnology and materials science. Important research in medicine and biology relies on nuclear magnetic resonance (NMR) spectroscopy, but until now, it has been limited in spatial resolution and typically requires powerful microwave fields. A team of researchers at the University of Melbourne has used a quantum probe to perform microwave-free NMR at the nanoscale. This quantum probe delivers a dramatic improvement in NMR technology. In addition to being able to detect NMR in far smaller samples than conventional machines, the technique does not require the application of microwave fields that might disrupt biological samples. The discovery may overcome significant limitations with conventional NMR methods, which depend on machines that can exceed 10 tonnes. With these advances in quantum sensing technology, doors can open to a new world of scientific investigation that could lead us to gain a better understanding of the smallest building blocks of life. Read more from the original source: Researchers in Melbourne provide new … Continue reading →

Shares in Prana Biotechnology (NADSAQ:PRAN) surged 19% and was earlier higher in New York as it said an article about early data on PBT434 had been accepted in a peer review journal. The article deals with the fact the compound PBT434 prevents iron-mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinsons disease. Dr David Stamler, Pranas chief medical officer, said: These findings are important because Parkinsons disease and the related synucleinopathies cause significant disability and diminish the independence of afflicted individuals. "An agent which slows disease progression could have a great impact on reducing disease burden and improving quality of life. We are eager to begin clinical testing of PBT434. The publication is the culmination of ten years of research from scientists at the Florey Institute of Neuroscience and Mental Health, (Melbourne, Australia), investigating compounds from Prana Biotechnologys propriety chemical library. Not only was PBT434 shown to block alpha-synuclein accumulation, but it also prevented loss of nerve cells in the region of the brain primarily affected in Parkinsons disease. To investigate the therapeutic potential of PBT434 to slow neurodegeneration, the researchers performed extensive animal testing in multiple Parkinsons disease models, including tests in mice that over-expressed the alpha-synuclein protein. … Continue reading →

The Economic and Financial Crimes Commission, EFCC, says it has arrested Lucy Ogbadu, the Director-General of National Biotechnology Development Agency (NABDA), over alleged N23 million fraud. The spokesperson of the commission, Wilson Uwujaren, disclosed this in a statement he issued on Thursday. Mr. Uwujaren said Ms. Ogbadu was picked up by EFCC operatives in Port Harcourt on Wednesday, following her alleged link with the Bayelsa State Director of Bio-resources Development Centre, Josiah Habu. Mr. Habu, according to him, is being investigated by the anti-graft agency in a case of fraudulent diversion of N75 million. He said investigations by the EFCC revealed that Ms. Ogbadu allegedly received N23 million through a bank account belonging to the wife of Mr. Habu, Esther Habu. The EFCC spokesperson stated that Ms. Ogbadu admitted the transaction in a voluntary statement made to the commissions investigators. Further investigations also revealed that Mrs Habu is one of the contractors with Bio-resources Development Centre, Odi, Bayelsa State. A total of N603 million has been traced to her in different deals involving over 20 directors of the centre across the country. Ogbadus involvement is being investigated. She has been duly served with bail conditions while investigations continue, Mr. Uwujaren … Continue reading →

Genome editing specialist Cellectis has kicked off clinical tests in the US for the very first of-the-shelf CAR-T cell therapy in acute myeloid leukaemia. The company said it enrolled the first patient with acute myeloid leukaemia (AML) to be treated with UCART123 at Weill at Cornell Medicine, New York Presbyterian Hospital. UCART123 is a TALEN-genome edited chimeric T cell receptor targeting the CD123/IL3R antigen on the surface of blasts and dendric cells, which is administered on allogeneic donor T cells. The team of Gail J. Roboz will investigate the safety and will collect first indications for efficacy of UCART123 in patients with AML. The Phase I trial is part of a strategic translational research alliance that was formed between Cellectis and Weill Cornell Medicine in 2015. While Novartis AG and Kite Pharma are leading the CAR-T cell therapy development in AML, Cellectis hopes to overtake its competitors. It has the only approach that works with allogenic CAR-engineered T cells that could be centrally pre-manufactured in contrast to the autologous patient T cells. Those need to be isolated, engineered and expanded during the at least 14 day hospital stay of the patients to be treated making the procedure costly, lengthy and … Continue reading →

Newswise Industrial biotechnology scientists, educators, entrepreneurs and executives from around the globe will be convening on the University of California San Diego campus this summer to explore the latest advances and world-changing innovations heating up the white-hot field of industrial biotechnology with workshops in microbial fermentation and metabolic engineering. UC San Diego Extension will host its annual Industrial Biotechnology Workshops on Aug. 14 through 18. Participants can attend the whole program or attend the workshops on microbial fermentation or metabolic engineering separately. Now in its fifth year, this widely acclaimed educational event creates an informal, intimate environment for robust exchange of knowledge and ideas among world-class academic instructors and leaders of cutting-edge companies of every size from startup to mature, said Hugo Villar, associate dean of Professional & Continuing Education for UC San Diego Extension. Whether from California or China, biotechnology professionals attending these workshops will have a front-row seat to learn about current developments and advanced scientific skills being used to solve some the worlds most difficult problems, Villar said. Microbial Fermentation For the past four years, the workshop focused primarily on microbial fermentation, which is the transformation of feedstocks, such as plant sugars, into useful products, like fuels, … Continue reading →

The new skin care line is expected to be launched in the third calendar quarter of 2017. CBD Biotechnology Co. Ltd. plans to use multiple sales channels to implement its sales plan including Tmall, TaoBao, the Company's official website, broadcasting platforms of internet celebrities, mobile news applications, and a multi-level direct selling system in cooperation with Shangdong Yibao Biologics Co. Ltd. "Following the launch of OptHemp Ultra Premium Hemp Oil by CIIX's wholly owned U.S. subsidiary, ChineseHempOil.com, Inc., I am very pleased to announce the launch of CBD Biotechnology Co., Ltd. non-industrial hemp infused skin care line," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "CBD Biotechnology Co., Ltd. will be one of the first companies in China to incorporate hemp-based CBD into skin care products, which we believe will spark public interest. "An estimated 55,700 metric tons of industrial hemp are produced around the world each year with China, Russia, and South Korea leading in production, accounting for 70 percent of the world's industrial hemp supply. Although China is one of the leading producers of industrial hemp, the benefits to the human body have not yet been widely recognized in mainland China," says Yun. "As one of the … Continue reading →

Bengaluru: The Karnataka IT and Biotechnology department on Wednesday granted Rs 3.18 crore to fund 12 start-ups in the areas of agriculture, biotechnology, security, communications and robotics. "The dozen start-ups have been selected for funding to innovate products and solutions as they have been part of the Idea2PoC (Proof of Concept) scheme of the IT department's Start-up Cell," said an official statement in Bengaluru. The Idea2PoC is a part of the country's first multi-sector start-up policy, unveiled by the state government to encourage entrepreneurs with funding to commercialise their innovation. The start-ups with seed funding are Dr. Live Software (Rs 10 lakh), EasyKrishi (Rs 15 lakh), Lightmetrics (Rs 30 lakh), PiOctave Solutions (Rs 30 lakh), Geeksynergey Technologies (Rs 30 lakh), ispAgro Robotics (Rs 20 lakh), Astrome (Rs 30 lakh), Esyasoft (Rs 20 lakh), Geotraq Safety (Rs 45 lakh), NammaNimma Cycle Foundation (Rs 10 lakh), Sirena Technologies (Rs 48 lakh) and Selfdot Technologies (Rs 30 lakh). "Though Bengaluru is the country's IT hub, we are seeing its start-up culture spreading to other areas, including agriculture, biotechnology, security, communications, robotics and gaming rapidly. Our aim is to mentor and help them to become self-sufficient," said IT & BT Principal Secretary Gaurav Gupta … Continue reading →

Our mission: providing reliable solutions for the bioprocess market that will enable an improved quality of life Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale. We are the only company that can take a customer from the initial screening stage up to full-scale production using the same platform. This minimizes scale-up risks and guarantees the shortest time to market for our customers new product development. Applikon is known for bringing new technologies to the market. These new technologies offer advantages in process efficiency for research and development as well as pilot plant and production scale processes. As a focused medium sized company we live by our motto A Step Ahead to differentiate ourselves from other suppliers. Our focus on developing bioreactor systems only, allows us to produce state-of-the-art equipment. This has resulted in a steady growth to the top position of the worldwide laboratory bioreactor market. The basis for our new product development lies in our strong cooperation with leading international universities and institutes. As a privately owned company our focus is not on short-term shareholders value but on building a healthy company by supplying the best product offering … Continue reading →

Newswise Industrial biotechnology scientists, educators, entrepreneurs and executives from around the globe will be convening on the University of California San Diego campus this summer to explore the latest advances and world-changing innovations heating up the white-hot field of industrial biotechnology with workshops in microbial fermentation and metabolic engineering. UC San Diego Extension will host its annual Industrial Biotechnology Workshops on Aug. 14 through 18. Participants can attend the whole program or attend the workshops on microbial fermentation or metabolic engineering separately. Now in its fifth year, this widely acclaimed educational event creates an informal, intimate environment for robust exchange of knowledge and ideas among world-class academic instructors and leaders of cutting-edge companies of every size from startup to mature, said Hugo Villar, associate dean of Professional & Continuing Education for UC San Diego Extension. Whether from California or China, biotechnology professionals attending these workshops will have a front-row seat to learn about current developments and advanced scientific skills being used to solve some the worlds most difficult problems, Villar said. Microbial Fermentation For the past four years, the workshop focused primarily on microbial fermentation, which is the transformation of feedstocks, such as plant sugars, into useful products, like fuels, … Continue reading →